Search Results 1671-1680 of 17410 for Cyclophosphamide
This is a Phase 1/2, open-label, dose-escalation, dose-expansion study for the treatment of patients with advanced cancers. Eligible patients with DLBCL or ...
JACKSONVILLE, Fla. — Mayo Clinic's pioneering exploration of stem cell-based therapies for bone loss is headed to space. Abba Zubair, M.D., Ph.D., is medical ...
Latest stories · Mayo Clinic No. · Mayo Clinic ranked No. · Infectious Disease A–Z: Will there be a universal flu vaccine? · Mayo Clinic, Boston Scientific launch ...
ROCHESTER, Minn. — Mayo Clinic researchers have developed a new artificial intelligence (AI) tool that helps clinicians identify brain activity patterns ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.
ROCHESTER, Minn. — Mayo Clinic now offers a free app called Mayo Clinic on Pregnancy, available in the Windows Store. MULTIMEDIA ALERT: Video of a[...].
A Study Of Ifinatamab Deruxtecan In Subjects With Pretreated Advanced Or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01) · Overview.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.